January 23, 2014
Chuikyo General Assembly A total of 11 active pharmaceutical ingredients (APIs)/22 products will go through price cuts in the FY2014 NHI price revision due to their larger-than-expected sales, including dipeptidyl peptidase-4 (DPP-4) inhibitor Januvia/Glactiv (sitagliptin) and rheumatoid arthritis (RA) drug...read more